RSCM
Rock Springs Capital Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-612,215
| Closed | -$1.3M | – | 108 |
|
|
2023
Q3 | $1.3M | Hold |
612,215
| – | – | 0.03% | 105 |
|
|
2023
Q2 | $2.91M | Hold |
612,215
| – | – | 0.07% | 98 |
|
|
2023
Q1 | $3.49M | Buy |
612,215
+502,215
| +457% | +$2.86M | 0.08% | 97 |
|
|
2022
Q4 | $1.11M | Hold |
110,000
| – | – | 0.03% | 111 |
|
|
2022
Q3 | $2.47M | Hold |
110,000
| – | – | 0.06% | 110 |
|
|
2022
Q2 | $2.73M | Hold |
110,000
| – | – | 0.08% | 109 |
|
|
2022
Q1 | $4.27M | Hold |
110,000
| – | – | 0.11% | 107 |
|
|
2021
Q4 | $6.44M | Hold |
110,000
| – | – | 0.15% | 110 |
|
|
2021
Q3 | $6.52M | Buy |
110,000
+40,000
| +57% | +$2.37M | 0.14% | 122 |
|
|
2021
Q2 | $6.08M | Hold |
70,000
| – | – | 0.12% | 132 |
|
|
2021
Q1 | $5.77M | Buy |
+70,000
| New | +$5.77M | 0.13% | 128 |
|